We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Chip Detects Intracardiac Ventricular Fibrillation

By HospiMedica International staff writers
Posted on 07 May 2013
A new low-power intracardiac signal-processing chip for cardiac resynchronization therapy (CRT) helps detect ventricular fibrillation.

Developed by researcher at IMEC (Leuven, Belgium), the new chip delivers innovative signal processing functionalities and consumes only 20 µW when all channels are active, enabling the miniaturization of implantable devices. More...
The integrated circuit features three power-efficient, intracardiac electrocardiogram (ECG) signal readout channels; each of the three channels is equipped with a precision ECG signal readout circuit with very low-power consumption and an analog signal processor to extract the features of signal for detection of ventricular fibrillation.

The feature extractor achieves only 2 ms latency to facilitate responsive CRT. The chip also includes features that improve the functionality of CRT devices, such as a low-power accelerometer readout channel that enables rate adaptive pacing, and a 16-level digital sinusoidal current generator to handle intra-thoracic fluid analysis. The generator provides 82 db wide dynamic range bioimpedance measurement, in the range of 0.1–4.4 kΩ with 35 mΩ resolution, achieving over 97% accuracy. The chip was presented at the International Solid State Circuits Conference (ISSCC), held during February 2013 in San Francisco (CA, USA).

Robust and accurate heart rate monitoring of the right and left ventricles and right atrium is essential for CRT implantable devices. Accurate motion sensor and thoracic impedance measurements to analyze intra-thoracic fluid are critical for improving clinical research and analysis of the intracardiac rhythm. Moreover, extreme low-power consumption is required to further reduce the size of cardiac implants and improve the patient's quality of life.

Related Links:

IMEC




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Rapid Sepsis Test
SeptiCyte RAPID
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Coredio’s CPSE is a a software-as-a-medical-device platform designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision (Photo courtesy of Coredio)

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.